MARKET

OGN

OGN

ORGANON & CO
NYSE
13.89
0.00
0.00%
After Hours: 13.89 0 0.00% 16:43 11/11 EST
OPEN
13.89
PREV CLOSE
13.89
HIGH
13.89
LOW
13.86
VOLUME
1.87M
TURNOVER
--
52 WEEK HIGH
13.89
52 WEEK LOW
5.67
MARKET CAP
3.65B
P/E (TTM)
18.06
1D
5D
1M
3M
1Y
5Y
1D
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
NASDAQ · 1d ago
Weekly Report: what happened at OGN last week (1102-1106)?
Weekly Report · 2d ago
Reported Saturday, Organon Presents Real-World Data At ACR Showing 1.3% Switchback Rate After Over 16,000 US Veterans Switched From HUMIRA To HADLIMA
Benzinga · 2d ago
Organon announces poster presentation on Hadlima at ACR Meeting
TipRanks · 3d ago
How Humira Switch Data Will Impact Organon Stock
Simply Wall St · 3d ago
New Real-World Evidence Presented by Organon at the American College of Rheumatology (ACR) Annual Meeting Evaluated a Large-Scale Switch to HADLIMA® (adalimumab-bwwd) Across United States Veterans Affairs Healthcare System
Barchart · 4d ago
Can Organon (OGN) Justify Its Valuation Following New VTAMA Phase 3 Data?
Simply Wall St · 4d ago
Organon Updates Pediatric Psoriasis Study as Tapinarof Expansion Nears a Key Milestone
TipRanks · 6d ago
More
About OGN
Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.

Webull offers Organon & Co stock information, including NYSE: OGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OGN stock methods without spending real money on the virtual paper trading platform.